Patents by Inventor Visesato MOR

Visesato MOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
    Publication number: 20220298103
    Abstract: The present invention provides a compound having the structure:
    Type: Application
    Filed: April 20, 2022
    Publication date: September 22, 2022
    Applicant: The Research Foundation for The State University of New York
    Inventors: Maurizio Del Poeta, Visesato Mor
  • Anti-fungals targeting the synthesis of fungal shingolipids
    Patent number: 11390580
    Abstract: The present invention provides a compound having the structure:
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: July 19, 2022
    Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: Maurizio Del Poeta, Visesato Mor
  • ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
    Publication number: 20200062698
    Abstract: The present invention provides a compound having the structure:
    Type: Application
    Filed: June 24, 2019
    Publication date: February 27, 2020
    Applicant: The Research Foundation for the State University of New York
    Inventors: Maurizio Del Poeta, Visesato Mor
  • ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
    Publication number: 20180141897
    Abstract: The present invention provides a compound having the structure:
    Type: Application
    Filed: December 7, 2015
    Publication date: May 24, 2018
    Applicant: The Research Foundation for the State University of New York
    Inventors: Maurizio Del Poeta, Visesato Mor
  • FUNGAL GLUCOSYLCERAMIDE AS A VACCINE FOR FUNGAL INFECTIONS
    Publication number: 20170224790
    Abstract: The present invention features compositions that include a fungal glucosylceramide (GlcCer) purified from a non-pathogenic fungus (e.g., Candida utilis) and, optionally, an adjuvant. The invention also features methods of treating a patient who has a fungal disease and methods of preventing a fungal disease in a subject by administration of these compositions. Also within the scope of the invention are methods of formulating a fungal vaccine by: (a) providing a fungal glucosylceramide isolated from a non-pathogenic fungus; and (b) combining the fungal glucosylceramide with an adjuvant in a physiologically acceptable excipient.
    Type: Application
    Filed: September 30, 2015
    Publication date: August 10, 2017
    Applicants: KOHJIN LIFE SCIENCES CO., LTD., THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: Maurizio DEL POETA, Visesato MOR, Toshiya SATO, Tomohiro NAKAGAWA